Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

154.04
-4.0300-2.55%
Post-market: 154.190.1500+0.10%16:25 EDT
Volume:20.21M
Turnover:3.13B
Market Cap:61.50B
PE:-19.24
High:159.79
Open:158.36
Low:150.26
Close:158.07
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:1.61
T/O Rate:5.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:9.10
PE(LYR):-21.22

Loading ...

Krystal Biotech Q2 Revenue Rises on Vyjuvek Strength

Reuters
·
Aug 03

Israel's Compugen Q2 Revenue More than Doubles, Net Loss Narrows

Reuters
·
Aug 03

Indivior Pharmaceuticals Beats Q2 Revenue on Sublocade Growth, Raises FY Guidance

Reuters
·
Aug 03

China's WuXi AppTec H1 Revenue Rises, Raises 2026 Guidance

Reuters
·
Aug 03

Does Moderna’s Wider 2026 Loss Amid Pipeline Spend Change The Bull Case For MRNA?

Simply Wall St.
·
Aug 03

Moderna Inc. Stock Slips 5.4%, Underperforms Peers

Dow Jones
·
Aug 01

Moderna Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 01

Analysts Offer Insights on Healthcare Companies: Moleculin Biotech (MBRX), Merit Medical Systems (MMSI) and Moderna (MRNA)

TIPRANKS
·
Aug 01

Moderna Burns Cash, Suffers Fresh Vaccine Setback

Benzinga Earnings
·
Jul 31

Apple, Amazon, Reddit, Micron, SK Hynix, Roblox, and More Stocks That Explain Today's Market

Dow Jones
·
Jul 31

Moderna's Vaccine Pipeline Comes into Focus

Dow Jones
·
Jul 31

Moderna Stock Has Doubled This Year. Can Earnings Keep the Rally Alive?

Dow Jones
·
Jul 31

Moderna Q2 2026 Earnings: Lower Costs Narrow the Net Loss

TradingKey
·
Jul 31

Moderna Narrows 2Q Loss, Says New Norovirus Vaccine Didn't Meet Expectations in Late-Stage Trial

Dow Jones
·
Jul 31

Moderna Earnings are Better than Expected so Why is the Stock Falling?

Dow Jones
·
Jul 31

Moderna Beats Quarterly Revenue Estimates Ahead of Key US Flu Vaccine Decision

Reuters
·
Jul 31

Moderna Q2 EPS USD -1.97 Vs. IBES Estimate USD -2.08

Reuters
·
Jul 31

Moderna Posts Smaller-than-expected Q2 Loss Per Share on Lower R&D Spending

Reuters
·
Jul 31

Earnings Flash (MRNA) Moderna Posts Q2 Loss $1.97 a Share, vs. FactSet Est of $2.01 Loss

MT Newswires Live
·
Jul 31

Moderna Q2 FY26 Net Loss Narrows 5% to $0.8 Billion; Revenue Rises to $145 Million

Reuters
·
Jul 31